Page last updated: 2024-08-22

diallyl trisulfide and Arteriosclerosis, Coronary

diallyl trisulfide has been researched along with Arteriosclerosis, Coronary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, YY; Nie, XM; Shi, DM; Su, LX; Zhao, YX; Zhou, YJ; Zhou, ZM1
Li, X; Nie, X; Shang, M; Su, L; Wei, Y; Zhou, Y1

Trials

1 trial(s) available for diallyl trisulfide and Arteriosclerosis, Coronary

ArticleYear
[Effects of allitridi capsules on endothelial function and clinical prognosis after percutaneous coronary intervention in coronary artery disease patients with diabetes mellitus].
    Zhonghua yi xue za zhi, 2013, Jul-09, Volume: 93, Issue:26

    Topics: Aged; Allyl Compounds; Capsules; Coronary Artery Disease; Diabetic Angiopathies; Endothelium, Vascular; Female; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Nitric Oxide; Percutaneous Coronary Intervention; Postoperative Period; Sulfides

2013

Other Studies

1 other study(ies) available for diallyl trisulfide and Arteriosclerosis, Coronary

ArticleYear
[Effects of allitridi capsules on endothelial function and clinical prognosis in coronary artery disease patients with obstructive sleep apnea hypopnea syndrome].
    Zhonghua yi xue za zhi, 2014, Jul-22, Volume: 94, Issue:28

    Topics: Allyl Compounds; Capsules; Coronary Artery Disease; Endothelin-1; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Humans; Nitric Oxide; Prognosis; Sleep Apnea, Obstructive; Sulfides

2014